TR201902981T4 - N-(4-kloro-2-hidroksi-3-((3s)-3-piperidinilsülfonil)fenil)-n'-(3-floro-2-metilfenil)ürenin hidrobromür tuzu. - Google Patents
N-(4-kloro-2-hidroksi-3-((3s)-3-piperidinilsülfonil)fenil)-n'-(3-floro-2-metilfenil)ürenin hidrobromür tuzu. Download PDFInfo
- Publication number
- TR201902981T4 TR201902981T4 TR2019/02981T TR201902981T TR201902981T4 TR 201902981 T4 TR201902981 T4 TR 201902981T4 TR 2019/02981 T TR2019/02981 T TR 2019/02981T TR 201902981 T TR201902981 T TR 201902981T TR 201902981 T4 TR201902981 T4 TR 201902981T4
- Authority
- TR
- Turkey
- Prior art keywords
- piperidinylsulfonyl
- methylphenyl
- fluoro
- chloro
- urea
- Prior art date
Links
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 title abstract 2
- -1 4-chloro-2-hydroxy-3 - ((3s) -3-piperidinylsulfonyl) phenyl Chemical group 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- NGYNBSHYFOFVLS-LBPRGKRZSA-N 1-[4-chloro-2-hydroxy-3-[(3s)-piperidin-3-yl]sulfonylphenyl]-3-(3-fluoro-2-methylphenyl)urea Chemical compound CC1=C(F)C=CC=C1NC(=O)NC1=CC=C(Cl)C(S(=O)(=O)[C@@H]2CNCCC2)=C1O NGYNBSHYFOFVLS-LBPRGKRZSA-N 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4462—Non condensed piperidines, e.g. piperocaine only substituted in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/452—Piperidinium derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1320021.7A GB201320021D0 (en) | 2013-11-13 | 2013-11-13 | Novel Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201902981T4 true TR201902981T4 (tr) | 2019-03-21 |
Family
ID=49818555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/02981T TR201902981T4 (tr) | 2013-11-13 | 2014-11-11 | N-(4-kloro-2-hidroksi-3-((3s)-3-piperidinilsülfonil)fenil)-n'-(3-floro-2-metilfenil)ürenin hidrobromür tuzu. |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US9809540B2 (OSRAM) |
| EP (1) | EP3068763B1 (OSRAM) |
| JP (1) | JP6401265B2 (OSRAM) |
| KR (1) | KR20160083950A (OSRAM) |
| CN (1) | CN105683162A (OSRAM) |
| AU (1) | AU2014350334B2 (OSRAM) |
| BR (1) | BR112016010409A8 (OSRAM) |
| CA (1) | CA2929907A1 (OSRAM) |
| CY (1) | CY1121581T1 (OSRAM) |
| DK (1) | DK3068763T3 (OSRAM) |
| ES (1) | ES2714721T3 (OSRAM) |
| GB (1) | GB201320021D0 (OSRAM) |
| HR (1) | HRP20190449T1 (OSRAM) |
| HU (1) | HUE041873T2 (OSRAM) |
| LT (1) | LT3068763T (OSRAM) |
| ME (1) | ME03328B (OSRAM) |
| PL (1) | PL3068763T3 (OSRAM) |
| PT (1) | PT3068763T (OSRAM) |
| RS (1) | RS58382B1 (OSRAM) |
| RU (1) | RU2685408C1 (OSRAM) |
| SI (1) | SI3068763T1 (OSRAM) |
| SM (1) | SMT201900156T1 (OSRAM) |
| TR (1) | TR201902981T4 (OSRAM) |
| WO (1) | WO2015071235A1 (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015173701A2 (en) * | 2014-05-12 | 2015-11-19 | Glaxosmithkline Intellectual Property (No. 2) Limited | Pharmaceutical compositions for treating infectious diseases |
| RU2018123711A (ru) | 2015-11-30 | 2020-01-09 | Глэксосмитклайн Интеллекчуал Проперти (Но.2) Лимитед | Композиции для внутривенного введения |
| WO2018073248A1 (en) | 2016-10-17 | 2018-04-26 | Icm (Institut Du Cerveau Et De La Moelle Épinière) | Prognosis of demyelinating diseases patients and treatment thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007240365B2 (en) | 2006-04-21 | 2011-12-15 | Glaxosmithkline Llc | IL-8 receptor antagonists |
-
2013
- 2013-11-13 GB GBGB1320021.7A patent/GB201320021D0/en not_active Ceased
-
2014
- 2014-11-11 AU AU2014350334A patent/AU2014350334B2/en not_active Ceased
- 2014-11-11 ME MEP-2019-47A patent/ME03328B/me unknown
- 2014-11-11 JP JP2016529894A patent/JP6401265B2/ja not_active Expired - Fee Related
- 2014-11-11 DK DK14799988.2T patent/DK3068763T3/en active
- 2014-11-11 KR KR1020167015530A patent/KR20160083950A/ko not_active Withdrawn
- 2014-11-11 HR HRP20190449TT patent/HRP20190449T1/hr unknown
- 2014-11-11 PL PL14799988T patent/PL3068763T3/pl unknown
- 2014-11-11 SI SI201431125T patent/SI3068763T1/sl unknown
- 2014-11-11 WO PCT/EP2014/074222 patent/WO2015071235A1/en not_active Ceased
- 2014-11-11 EP EP14799988.2A patent/EP3068763B1/en active Active
- 2014-11-11 SM SM20190156T patent/SMT201900156T1/it unknown
- 2014-11-11 HU HUE14799988A patent/HUE041873T2/hu unknown
- 2014-11-11 US US15/034,583 patent/US9809540B2/en not_active Expired - Fee Related
- 2014-11-11 RU RU2016116955A patent/RU2685408C1/ru not_active IP Right Cessation
- 2014-11-11 RS RS20190230A patent/RS58382B1/sr unknown
- 2014-11-11 CA CA2929907A patent/CA2929907A1/en not_active Abandoned
- 2014-11-11 CN CN201480061455.2A patent/CN105683162A/zh active Pending
- 2014-11-11 TR TR2019/02981T patent/TR201902981T4/tr unknown
- 2014-11-11 PT PT14799988T patent/PT3068763T/pt unknown
- 2014-11-11 LT LTEP14799988.2T patent/LT3068763T/lt unknown
- 2014-11-11 BR BR112016010409A patent/BR112016010409A8/pt not_active IP Right Cessation
- 2014-11-11 ES ES14799988T patent/ES2714721T3/es active Active
-
2017
- 2017-10-05 US US15/725,429 patent/US20180079722A1/en not_active Abandoned
-
2018
- 2018-12-13 US US16/218,602 patent/US10604485B2/en not_active Expired - Fee Related
-
2019
- 2019-02-26 CY CY20191100237T patent/CY1121581T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3068763B1 (en) | 2018-12-19 |
| EP3068763A1 (en) | 2016-09-21 |
| SMT201900156T1 (it) | 2019-05-10 |
| PT3068763T (pt) | 2019-03-20 |
| CA2929907A1 (en) | 2015-05-21 |
| CY1121581T1 (el) | 2020-05-29 |
| KR20160083950A (ko) | 2016-07-12 |
| ME03328B (me) | 2019-10-20 |
| US20160264525A1 (en) | 2016-09-15 |
| DK3068763T3 (en) | 2019-03-18 |
| ES2714721T3 (es) | 2019-05-29 |
| HUE041873T2 (hu) | 2019-05-28 |
| RS58382B1 (sr) | 2019-04-30 |
| AU2014350334A1 (en) | 2016-06-02 |
| AU2014350334B2 (en) | 2017-08-10 |
| GB201320021D0 (en) | 2013-12-25 |
| CN105683162A (zh) | 2016-06-15 |
| RU2016116955A (ru) | 2017-12-19 |
| WO2015071235A1 (en) | 2015-05-21 |
| PL3068763T3 (pl) | 2019-05-31 |
| US20190112269A1 (en) | 2019-04-18 |
| JP2016537344A (ja) | 2016-12-01 |
| US10604485B2 (en) | 2020-03-31 |
| JP6401265B2 (ja) | 2018-10-10 |
| US20180079722A1 (en) | 2018-03-22 |
| HRP20190449T1 (hr) | 2019-04-19 |
| BR112016010409A8 (pt) | 2020-04-22 |
| US9809540B2 (en) | 2017-11-07 |
| RU2685408C1 (ru) | 2019-04-18 |
| LT3068763T (lt) | 2019-03-12 |
| SI3068763T1 (sl) | 2019-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201690598A1 (ru) | Аминогетероарил бензамиды в качестве ингибиторов киназы | |
| EA201690019A1 (ru) | Производное аминотриазина и содержащая его фармацевтическая композиция | |
| EA201300200A1 (ru) | N-((6-аминопиридин-3-ил)метил)гетероарилкарбоксамиды в качестве ингибиторов калликреина в плазме | |
| EA201590224A1 (ru) | Имидазотриазинкарбонитрилы, используемые в качестве ингибиторов киназы | |
| MY169986A (en) | Benzimidazole-proline derivatives | |
| BR112015021983A8 (pt) | compostos heterocíclicos, composições e usos dos mesmos | |
| EA201690247A1 (ru) | Аминометилбиарильные производные-ингибиторы фактора d комплемента и их применения | |
| EA201190320A1 (ru) | Гетероциклические сульфонамиды, их применения и фармацевтические композиции | |
| EA201591756A1 (ru) | Метаболиты n-(4-{[6,7-бис-(метилокси)хинолин-4-ил]окси}фенил)-n'-(4-фторфенил)циклопропан-1,1-дикарбоксамида | |
| UA112317C2 (uk) | Похідні 2-(1,2,3-триазол-2-іл)бензаміду та 3-(1,2,3-триазол-2-іл)піколінаміду як антагоністи рецептора орексину | |
| EA201691119A1 (ru) | Производные мочевины или их фармакологически приемлемые соли | |
| EA201201050A1 (ru) | Пиразолы в качестве антагонистов crth2 | |
| TR201902057T4 (tr) | Tetrasiklin bileşikleri. | |
| EA029499B9 (ru) | Ингибиторы rorc2 и способы их применения | |
| CY1122077T1 (el) | Νεα δακτυλιωμενα φαινοξυακεταμιδια | |
| EA201400822A1 (ru) | Производные гетероциклических амидов в качестве антагонистов p2xрецептора | |
| PH12014502743A1 (en) | Carbamate/urea derivatives | |
| EA201890532A1 (ru) | Новые аннелированные бензамиды | |
| AR095350A1 (es) | Compuestos inhibidores de una histona deacetilasa y composición farmacéutica que los contiene | |
| MX2020008929A (es) | Compuestos de dihidropirimidinona o dihidrotriazinona fusionados con anillos saturados y su uso farmaceutico. | |
| EA201501163A1 (ru) | Модуляторы рецептора cxcr7 | |
| EA201600323A1 (ru) | Производные пиперазина и их применение в качестве лекарственного средства | |
| EA201300857A1 (ru) | Пиразолы в качестве антагонистов crth2 | |
| EA201000340A1 (ru) | Аминобензилзамещенные циклические сульфоны, полезные в качестве ингибиторов васе | |
| CY1121581T1 (el) | Υδροβρωμικο αλας n-(4-xλωpo-2-yδpoξy-3-((3s)-3-πιπεριδινυλσουλφονυλ)φαινυλ)-ν'-(3-φθορο-2-μεθυλφαινυλ)ουριας |